Skip to main content
. 2024 Oct 22;16(21):3589. doi: 10.3390/nu16213589

Table 1.

The baseline (T0) characteristics of the whole group (n = 109), of women (n = 51), and of men (n = 58). The data are reported as the mean ± standard deviation or number (%). p-values refer to the Mann–Whitney U test or the chi-squared test, as appropriate.

Baseline Characteristics Whole Group
(n = 109)
Women
(n = 51)
Men
(n = 58)
p-Value
Age (years) 69 ± 11 72 ± 9 67 ± 12 0.027 *
Index stroke type
Ischemic 86 (79%) 42 (82%) 44 (76%) 0.407
Hemorrhagic 23 (21%) 9 (18%) 14 (24%)
Affected side
Right 58 (53%) 27 (53%) 31 (56%) 0.958
Left 51 (47%) 24 (47%) 27 (47%)
Smoking habit (smokers and ex-smokers) 50 (46%) 19 (37%) 31 (53%) 0.103
Comorbidities
Hypertension 93 (85%) 44 (86%) 49 (84%) 0.792
Type 2 Diabetes 28 (26%) 12 (24%) 16 (28%) 0.629
Dyslipidemia 45 (41%) 22 (43%) 23 (40%) 0.713
Heart disease 16 (17%) 4 (9%) 12 (23%) 0.059
Dysphagia 49 (45%) 24 (43%) 25 (47%) 0.679
Cumulative Illness Rating Scale (CIRS)
CIRS severity 2.2 ± 0.4 2.2 ± 0.4 2.1 ± 0.4 0.066
CIRS comorbidity 5.1 ± 2.0 5.3 ± 1.9 4.9 ± 2.2 0.284
Days from stroke onset to enrollment 87 ± 57 97 ± 62 77 ± 52 0.079
Activities of daily living (ADLs) assessment
modified Barthel Index (0–100) 42 ± 22 37 ± 19 46 ± 24 0.094
Hematochemical analyses
Glucose (mg/dL) 111 ± 39 116 ± 45 105 ± 33 0.292
Cholesterol (mg/dL) 126 ± 36 133 ± 41 119 ± 31 0.207
High Density Lipoprotein (HDL) cholesterol (mg/dL) 53 ± 17 57 ± 15 49 ± 18 0.005 *
Ratio (cholesterol/HDL cholesterol) 2.5 ± 0.9 2.4 ± 0.8 2.6 ± 1.0 0.443
Triglycerides (mg/dL) 123 ± 58 120 ± 61 126 ± 56 0.372
Albumin (g/L) 3.8 ± 0.5 3.7 ± 0.5 3.9 ± 0.4 0.281
Nutritional status assessment
Anthropometric value
Weight (kg) 69.2 ± 17.1 62.2 ± 13.2 75.3 ± 17.9 <0.001 ***
Height (m) 1.66 ± 0.10 1.60 ± 0.67 1.71 ± 0.10 <0.001 ***
Body Mass Index (BMI; kg/m2) 24.9 ± 4.8 24.2 ± 5.1 25.5 ± 4.4 0.055

* p-value < 0.05; *** p-value < 0.001.